Image For Activity Cover
Best Practices in Cath Lab Management for STEMI Enduring
Program Description
Listen to an expert panel as they discuss the latest expert consensus on ST-elevation myocardial infarction (STEMI). Learn about best practices for cardiac catheterization laboratory readiness, arterial access, diagnostic angiography, and thrombus management. Discover strategies to improve outcomes and reduce mortality for STEMI patients.
Faculty and Program
Yader Sandoval, MD, FSCAI
Jacqueline Tamis-Holland, MD, FSCAI
Key Points and Algorithm
J. Dawn Abbott, MD, FSCAI
Case of STEMI with Refractory No-Reflow


Mauricio Cohen, MD, FSCAI
Case of STEMI in a Large Bifurcation Vessel

Celina Yong, MD, MBA, MSc, FSCAI
Case of STEMI With Large Thrombus Burden
  Anna Bortnick, MD, PhD, FSCAI
Nitin Barman, MD, FSCAI Tim Henry, MD, MSCAI
Learning Objectives
Upon completion of these activities, participants will be able to:

  1. To discuss the strengths and limitations of various diagnostic and therapeutic interventions to assess and treat a patient with STEMI in the Cath Lab
  2. To review the different options to manage large thrombus burden during STEMI, and to manage no-reflow
  3. To review the management of STEMI across the spectrum of various anatomical and clinical circumstances
Disclosures

Individuals in control of content reported the following relevant financial relationships with ineligible companies during the content development process for this activity. All relevant financial relationships were mitigated before the start of the activity.

Planner

Jacqueline Tamis-Holland: No financial relationships with ineligible companies

Faculty
J. Dawn Abbott: Consulting: Abbott; PI: Boston Scientific; Shockwave; Philips
Nitin Barman: Speaker: Boston Scientific; Cardiovascular Systems Inc.
Anna Bortnick: Grant: Zoll; Honoraria: Getinge, Zoll; PI: CSL-Behring, Amgen
Mauricio Cohen: Consulting: Abbott; PI: Abbott, Boston Scientific
Tim Henry: No financial relationships with ineligible companies
Yader Sandoval: Advisory Board: Abbott; Philips; Zoll
Celina Yong: No financial relationships with ineligible companies

Reviewer
Nkechi Ijioma and Adhir Shroff: No financial relationships with ineligible companies.

Staff
Alan Nguyen, Chelsea Armah, Scott Firestone: No financial relationships with ineligible companies.

Acknowledgement of Commercial Support
This activity is supported by unrestricted educational grants from Boston Scientific and Zoll.
Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit. 

Record Date: 10/01/2024
Publish Date: 11/18/2024
Expiration Date: 11/18/2027

Copyright
© 2024-2027 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Summary
Availability: On-Demand
Cost: Member: $0.00
Non-Member: $39.00
Fellow-In-Training: $0.00
Cardio Team Member: $0.00
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 Participation Credit
Powered By